News
Effective NASH medications are coming ‘sooner than you think’
SAN ANTONIO – New NASH drugs will transform clinical practice.
News
Endoscopic radiofrequency ablation excels for pancreatic tumors
SAN ANTONIO – Meta-analysis documents high clinical success rate with favorable safety profile.
News
Endoscopy-related occupational injuries run rampant in gastroenterology
SAN ANTONIO – Three-quarters of gastroenterologists have experienced endoscopy-related musculoskeletal injuries.
News
Endoscopy-related occupational injuries run rampant in gastroenterology
SAN ANTONIO – Three-quarters of gastroenterologists have experienced endoscopy-related musculoskeletal injuries.
News
Certolizumab safety profile varies widely across indications
MADRID – Systemic corticosteroid use and BMI impact risk of serious adverse events with certolizumab.
News
Wide-area transepithelial sampling may be best method for detecting esophageal intestinal metaplasia
SAN ANTONIO – Forceps biopsy versus WATS in randomized clinical trial showdown.
News
Oral baricitinib performs well in phase 3 for atopic dermatitis
MADRID – This is the first phase 3 study testing the efficacy of a JAK inhibitor in combination with low- and mid-potency topical steroids.
News
Geriatric IBD hospitalization carries steep inpatient mortality
SAN ANTONIO – A major unmet need exists for better guideline-directed management of geriatric patients hospitalized for IBD.
News
ISCHEMIA-CKD: No benefit for coronary revascularization in advanced CKD with stable angina
PHILADELPHIA – At 3 years, more than 27% of patients were dead regardless of the coronary artery disease management strategy.
News
IL-1 alpha is a new target in atopic dermatitis
MADRID – Bermekimab shows encouraging results in atopic dermatitis proof-of-concept study.
News
Satisfaction high among psoriasis patients on apremilast
MADRID – Over 12 months, the switch rate was significantly lower in patients who had started on apremilast than in those on a TNF inhibitor.
News
RNA inhibitors silence two new targets in dyslipidemia
PHILADELPHIA –
News
Apremilast for Behçet’s oral ulcers: Benefits maintained at 64 weeks
MADRID – Reassuring results of a long-term extension of the phase 3 RELIEF trial.
News
The TWILIGHT of aspirin post-PCI for ACS?
PHILADELPHIA –
Video
ISCHEMIA trial hailed as practice changing
PHILADELPHIA – The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves.